Melatonin was shown to inhibit cell proliferation of human breast cancer cells by binding to MT1 receptors and suppressing estrogen-induced estrogen receptor alpha (ERα) transcriptional activity [40]. The gene discussed is ESR1; the disease is breast carcinoma.